Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Cash Flows from Operating Activities:
Net loss	$ (409,491)		$ (394,883)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,030		11,905
Stock-based compensation expense	81,229		28,427
Changes in operating assets and liabilities:
Prepaid expenses	22,954		14,162
Accounts payable and accounts payable – related parties	(30,112)		(18,894)
Accrued expenses and accrued expenses – related parties	57,500		3,914
Net Cash Used in Operating Activities	(264,890)		(355,369)
Cash Flows from Investing Activities:
Cost of registering patents	(8,543)		(10,860)
Net Cash Used in Investing Activities	(8,543)		(10,860)
Cash Flows from Financing Activities:
Principal payments on notes payable	(23,291)		(20,965)
Issuance of common stock for cash	171,000		1,049,250
Net Cash Provided by Financing Activities	147,709		1,028,285
Effect of Foreign Currency Exchange Rates	18,231		514
Net (decrease) increase in cash	(107,493)		662,570
Cash as of beginning of the period	140,496	[1]	81,856
Cash as of end of the period	33,003		744,426
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	482		462
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 31,000		$ 27,169

[1] The condensed consolidated balance sheet as of December 31, 2014 has been prepared using information from the audited consolidated balance sheet as of that date.